# 4-HO-DiPT
*Source: https://psychonautwiki.org/wiki/4-HO-DiPT*

## Dosage & Duration

### Oral

**Dosage:**
- Threshold: 3 mg
- Light: 3 - 10 mg
- Common: 10 - 20 mg
- Strong: 20 - 30 mg
- Heavy: 30 mg +

**Duration:**
- Total: 2 - 4 hours
- Onset: 15 - 30 minutes
- Come up: 20 - 40 minutes
- Peak: 60 - 90 minutes
- Offset: 30 - 60 minutes

**4-Hydroxy-N,N-diisopropyltryptamine** (also known as **4-HO-DiPT** and **Iprocin** ) is a lesser-known [psychedelic](https://psychonautwiki.org/wiki/Psychedelic) substance of the [tryptamine](https://psychonautwiki.org/wiki/Tryptamine) class that produces [psilocin](https://psychonautwiki.org/wiki/Psilocin) -like [psychedelic](https://psychonautwiki.org/wiki/Psychedelic) effects when [administered](https://psychonautwiki.org/wiki/Administered) . It is the 4-hydroxy analog of [DiPT](https://psychonautwiki.org/wiki/DiPT) and is structurally related to tryptamines like [4-HO-DMT](https://psychonautwiki.org/wiki/4-HO-DMT) ( **Psilocin** ), [4-HO-MiPT](https://psychonautwiki.org/wiki/4-HO-MiPT) ( **Miprocin** ), and [4-HO-DET](https://psychonautwiki.org/wiki/4-HO-DET) ( **Ethocin** ).

Following the publication of its synthesis by David B. Repke in 1977, its effects in humans were investigated by [Alexander Shulgin](https://psychonautwiki.org/wiki/Alexander_Shulgin) . It is characterized in his 1997 book [TiHKAL](https://psychonautwiki.org/wiki/TiHKAL) ( *"Tryptamines I Have Known and Loved"* ) and is noted for being unique among psychedelics in terms of its speed (apparent 15 minutes after ingestion), intensity (20 milligrams can produce a transcendent peak experience), brevity (2-3 hours), and dose sensitivity. Additionally, idiosyncratic physical effects like muscle tremors and bodily malaise were noted.

Today, 4-HO-DiPT is used for both recreational and [entheogenic](https://psychonautwiki.org/wiki/Entheogen) purposes. It is relatively uncommon and occasionally distributed on the online [research chemical](https://psychonautwiki.org/wiki/Research_chemical) market. Very little is known about the pharmacological properties, metabolism, and toxicity in humans, and it has a limited history of human use. It is highly advised to use [harm reduction practices](https://psychonautwiki.org/wiki/Harm_reduction_practices) if using this substance.

## Chemistry

4-HO-DiPT, or 4-Hydroxy-N,N-diisopropyltryptamine, is a synthetic indole alkaloid molecule of the tryptamine chemical class. Tryptamines share a core structure comprised of a bicyclic indole heterocycle attached at R3 to an amino group via an ethyl side chain. 4-HO-DiPT is substituted at R4 of its indole heterocycle with a hydroxyl functional group OH−. It also contains two isopropyl groups bound to the terminal amine RN of its tryptamine backbone.

4-HO-DiPT is a 4-hydroxy analog of [DiPT](https://psychonautwiki.org/wiki/DiPT) and the N-substituted isopropyl homolog of [4-HO-DMT](https://psychonautwiki.org/wiki/4-HO-DMT) .

## Pharmacology

Like most [psychedelic](https://psychonautwiki.org/wiki/Psychedelic) tryptamines, 4-HO-DiPT is thought to act principally as a [5-HT2A](https://psychonautwiki.org/wiki/Serotonin#The_5-HT_system) [partial agonist](https://psychonautwiki.org/wiki/Agonist#Agonists) . The psychedelic effects are believed to come from 4-HO-DiPT's binding efficacy at the 5-HT 2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

## Subjective effects

***Disclaimer:** The effects listed below cite the [Subjective Effect Index](https://psychonautwiki.org/wiki/Subjective_effect_index) ( **SEI** ), an open research literature based on anecdotal user reports and the personal analyses of [PsychonautWiki](https://psychonautwiki.org/wiki/PsychonautWiki) [contributors](https://psychonautwiki.org/wiki/Special:TopUsers) . As a result, they should be viewed with a healthy degree of skepticism.*

*It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. *Likewise, **adverse effects** become increasingly likely with higher doses and may include **addiction, severe injury, or death*** ☠.*
### Physical effects
 
- - **[Stimulation](https://psychonautwiki.org/wiki/Stimulation)**
- **[Spontaneous physical sensations](https://psychonautwiki.org/wiki/Spontaneous_physical_sensations)**
- **[Increased heart rate](https://psychonautwiki.org/wiki/Increased_heart_rate)** [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]
- **[Increased blood pressure](https://psychonautwiki.org/wiki/Increased_blood_pressure)** [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]
- **[Nausea](https://psychonautwiki.org/wiki/Nausea)**
- **[Pupil dilation](https://psychonautwiki.org/wiki/Pupil_dilation)** ### Visual effects
 
- #### Enhancements
 
- **[Colour enhancement](https://psychonautwiki.org/wiki/Colour_enhancement)**
- **[Pattern recognition enhancement](https://psychonautwiki.org/wiki/Pattern_recognition_enhancement)**
- **[Visual acuity enhancement](https://psychonautwiki.org/wiki/Visual_acuity_enhancement)**
 
#### Distortions
 
- **[Drifting](https://psychonautwiki.org/wiki/Drifting)** *( [melting](https://psychonautwiki.org/wiki/Drifting#Melting) , [breathing](https://psychonautwiki.org/wiki/Drifting#Breathing) , [morphing](https://psychonautwiki.org/wiki/Drifting#Morphing) and [flowing](https://psychonautwiki.org/wiki/Drifting#Flowing) )*
- **[Colour shifting](https://psychonautwiki.org/wiki/Colour_shifting)**
- **[Depth perception distortions](https://psychonautwiki.org/wiki/Depth_perception_distortions)**
- **[Perspective distortions](https://psychonautwiki.org/wiki/Perspective_distortions)**
- **[Symmetrical texture repetition](https://psychonautwiki.org/wiki/Symmetrical_texture_repetition)**
- **[Tracers](https://psychonautwiki.org/wiki/Tracers)**
- **[After images](https://psychonautwiki.org/wiki/After_images)**
- **[Brightness alteration](https://psychonautwiki.org/wiki/Brightness_alteration)**
- **[Diffraction](https://psychonautwiki.org/wiki/Diffraction)**
 
#### Hallucinatory states
 
- **[Transformations](https://psychonautwiki.org/wiki/Transformations)**
- **[Internal hallucination](https://psychonautwiki.org/wiki/Internal_hallucination)** ( *[autonomous entities](https://psychonautwiki.org/wiki/Autonomous_entities)* ; *[settings, sceneries, and landscapes](https://psychonautwiki.org/wiki/Settings,_sceneries,_and_landscapes)* ; *[perspective hallucinations](https://psychonautwiki.org/wiki/Perspective_hallucinations)* and *[scenarios and plots](https://psychonautwiki.org/wiki/Scenarios_and_plots)* ) ### Cognitive effects
 
- - **[Conceptual thinking](https://psychonautwiki.org/wiki/Conceptual_thinking)**
- **[Cognitive euphoria](https://psychonautwiki.org/wiki/Cognitive_euphoria)**
- **[Delusion](https://psychonautwiki.org/wiki/Delusion)**
- **[Emotion enhancement](https://psychonautwiki.org/wiki/Emotion_enhancement)**
- **[Immersion enhancement](https://psychonautwiki.org/wiki/Immersion_enhancement)**
- **[Increased music appreciation](https://psychonautwiki.org/wiki/Increased_music_appreciation)**
- **[Memory suppression](https://psychonautwiki.org/wiki/Memory_suppression)** 
- **[Ego death](https://psychonautwiki.org/wiki/Ego_death)**
- **[Novelty enhancement](https://psychonautwiki.org/wiki/Novelty_enhancement)**
- **[Personal bias suppression](https://psychonautwiki.org/wiki/Personal_bias_suppression)**
- **[Thought loops](https://psychonautwiki.org/wiki/Thought_loops)**
- **[Time distortion](https://psychonautwiki.org/wiki/Time_distortion)** ### Auditory effects
 
- - **[Auditory enhancement](https://psychonautwiki.org/wiki/Auditory_enhancement)**
- **[Auditory distortion](https://psychonautwiki.org/wiki/Auditory_distortion)**
- **[Auditory hallucination](https://psychonautwiki.org/wiki/Auditory_hallucination)** ### Transpersonal effects
 
- - **[Unity and interconnectedness](https://psychonautwiki.org/wiki/Unity_and_interconnectedness)**
### Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our [experience index](https://psychonautwiki.org/wiki/Experience_index) . Additional experience reports can be found here:

- [Erowid Experience Vaults: 4-HO-DiPT](https://erowid.org/experiences/subs/exp_4HODiPT.shtml)

## Toxicity and harm potential

The toxicity and long-term health effects of recreational 4-HO-DiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 4-HO-DiPT is a [research chemical](https://psychonautwiki.org/wiki/Research_chemical) with very little history of human usage.

Anecdotal reports from those who have tried 4-HO-DiPT suggests that there are no negative health effects attributed to simply trying it by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [Independent research](https://www.google.com/) should always be done to ensure that a combination of two or more substances is safe before consumption.

It is strongly recommended that one use [harm reduction practices](https://psychonautwiki.org/wiki/Responsible_drug_use) when using this drug.

### Tolerance and addiction potential

4-HO-DiPT is not habit-forming, and the desire to use it can actually decrease with regular consumption. Like with most [psychedelics](https://psychonautwiki.org/wiki/Psychedelics) , it is most often thought to be self-regulating.

Tolerance to the effects of 4-HO-DiPT is built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 4-HO-DiPT presents cross-tolerance with all [psychedelics](https://psychonautwiki.org/wiki/Psychedelic) , meaning that after the consumption of 4-HO-DiPT all psychedelics will have a reduced effect.

### Dangerous interactions

***Warning:*** *Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).*

*Always conduct independent research (e.g. [Google](https://www.google.com) , [DuckDuckGo](https://www.duckduckgo.com) , [PubMed](https://pubmed.ncbi.nlm.nih.gov/) ) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from [TripSit](https://combo.tripsit.me) .*

- **[Lithium](http://en.wikipedia.org/wiki/Lithium_(medication))** - Lithium is commonly prescribed for the treatment of [bipolar disorder](https://en.wikipedia.org/wiki/Bipolar_disorder) . There is a large body of anecdotal evidence that suggests taking it with [psychedelics](https://psychonautwiki.org/wiki/Psychedelics) significantly increases the risk of [psychosis](https://psychonautwiki.org/wiki/Psychosis) and [seizures](https://psychonautwiki.org/wiki/Seizures) . As a result, this combination is strictly discouraged.
- **[Cannabis](https://psychonautwiki.org/wiki/Cannabis)** - Cannabis may have an unexpectedly strong and unpredictable synergy with the effects of 4-HO-DiPT. Caution is advised with this combination as it can significantly increase the risk of adverse psychological reactions like [anxiety](https://psychonautwiki.org/wiki/Anxiety) , [paranoia](https://psychonautwiki.org/wiki/Paranoia) , [panic attacks](https://psychonautwiki.org/wiki/Panic_attacks) , and [psychosis](https://psychonautwiki.org/wiki/Psychosis) . Users are advised to start off with only a fraction of their normal cannabis dose and take long breaks between hits to avoid unintentional overdose.
- **[Stimulants](https://psychonautwiki.org/wiki/Stimulants)** - Stimulants like [amphetamine](https://psychonautwiki.org/wiki/Amphetamine) , [cocaine](https://psychonautwiki.org/wiki/Cocaine) or [methylphenidate](https://psychonautwiki.org/wiki/Methylphenidate) affect many parts of the brain and alter [dopaminergic](https://psychonautwiki.org/wiki/Dopamine) function. This combination can increase the risk of [anxiety](https://psychonautwiki.org/wiki/Anxiety) , [paranoia](https://psychonautwiki.org/wiki/Paranoia) , [panic attacks](https://psychonautwiki.org/wiki/Panic_attacks) , and [thought loops](https://psychonautwiki.org/wiki/Thought_loops) . This interaction may also result in an elevated risk of [mania](https://psychonautwiki.org/wiki/Mania) and [psychosis](https://psychonautwiki.org/wiki/Psychosis) . [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]
- **[Tramadol](https://psychonautwiki.org/wiki/Tramadol)** - Tramadol is well-documented to lower the seizure threshold and [psychedelics](https://psychonautwiki.org/wiki/Psychedelics) may act to trigger seizures in susceptible individuals. [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]

## Legal status

Due to its relative obscurity, the possession and sale of 4-HO-DiPT is unscheduled in most countries.

- **Germany** : 4-HO-DiPT is controlled under the NpSG ( *New Psychoactive Substances Act* ) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable. The legislator considers it possible that orders of 4-HO-DiPT are punishable as an incitement to place it on the market.
- **Sweden** : 4-HO-DiPT is classified as a "health hazard" under the act "Lagen om förbud mot vissa hälsofarliga varor" (translated to the "Act on the Prohibition of Certain Goods Dangerous to Health") as of March 1, 2005 in their regulation SFS 2005:26, making it illegal to sell or possess.
- **Switzerland** : 4-HO-DiPT is not controlled under Buchstabe A, B, C and D. It could be considered legal.
- **United Kingdom** : 4-HO-DiPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.
- **United States** : 4-HO-DiPT is unscheduled in the United States. It may be considered an analogue of [psilocin](https://psychonautwiki.org/wiki/Psilocin) ( *4-HO-DMT* ), a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act. [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*] 
- **Florida** : 4-HO-DiPT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.

## See also

- [Responsible use](https://psychonautwiki.org/wiki/Responsible_use)
- [Research chemical](https://psychonautwiki.org/wiki/Research_chemical)
- [Psychedelic](https://psychonautwiki.org/wiki/Psychedelic)
- [Tryptamine](https://psychonautwiki.org/wiki/Tryptamine)
- [4-AcO-DiPT](https://psychonautwiki.org/wiki/4-AcO-DiPT)
- [DiPT](https://psychonautwiki.org/wiki/DiPT)

## External links

- [4-HO-DiPT (Wikipedia)](https://en.wikipedia.org/wiki/4-HO-DiPT)
- [4-HO-DiPT (Erowid Vault)](https://erowid.org/chemicals/4_ho_dipt/4_ho_dipt.shtml)
- [4-HO-DiPT (TiHKAL / Isomer Design)](https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=17)

### Community

- [The Big & Dandy 4-HO-DiPT Thread (Bluelight)](http://www.bluelight.org/vb/threads/57739-The-Big-amp-Dandy-4-HO-DiPT-Thread)

## References
1. ↑ 1.0 1.1 [Shulgin, Alexander](https://psychonautwiki.org/wiki/Alexander_Shulgin); Shulgin, Ann (1997).["#17. 4-HO-DIPT"](https://erowid.org/library/books_online/tihkal/tihkal17.shtml).*[TiHKAL: The Continuation](https://psychonautwiki.org/wiki/TiHKAL)*. United States: Transform Press.[ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number)[0-9630096-9-9](http://en.wikipedia.org/wiki/Special:BookSources/0-9630096-9-9).[OCLC](http://en.wikipedia.org/wiki/OCLC)[38503252](//www.worldcat.org/oclc/38503252).
2. ↑ Repke, D. B.; Ferguson, W. J.; Bates, D. K. (1977). "Psilocin analogs. 1. Synthesis of 3‐[2‐(dialkylamino)ethyl] ‐and 3‐[2‐(cycloalkylamino)ethyl] indol‐4‐ols".*Journal of Heterocyclic Chemistry*.**14**(1): 71–74.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1002/jhet.5570140113](//doi.org/10.1002%2Fjhet.5570140113).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0022-152X](//www.worldcat.org/issn/0022-152X).[OCLC](http://en.wikipedia.org/wiki/OCLC)[1783072](//www.worldcat.org/oclc/1783072).
3. ↑ [Alexander Shulgin](https://psychonautwiki.org/wiki/Alexander_Shulgin)(1980).[Pharmacology Notes II (The Shulgin Lab Books)](https://erowid.org/library/books_online/shulgin_labbooks/shulgin_pharmacology_notebook9_searchable.pdf)(PDF). Lafayette, CA: Erowid. p. 293.
4. ↑ Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009). "Dose-independent occurrence of seizure with tramadol".*Journal of Medical Toxicology*.**5**(2): 63–67.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/BF03161089](//doi.org/10.1007%2FBF03161089).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[1556-9039](//www.worldcat.org/issn/1556-9039).
5. ↑ ["Anlage NpSG"](https://www.gesetze-im-internet.de/npsg/anlage.html)(in German). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
6. ↑ ["Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes"](http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl119s1083.pdf)(PDF).*Bundesgesetzblatt Jahrgang 2019 Teil I Nr. 27*(in German). Bundesanzeiger Verlag. July 17, 2019. pp. 1083–1094.[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0341-1095](//www.worldcat.org/issn/0341-1095).
7. ↑ ["§ 4 NpSG"](https://www.gesetze-im-internet.de/npsg/__4.html)(in German). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
8. ↑ ["§ 3 NpSG"](https://www.gesetze-im-internet.de/npsg/__3.html)(in German). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
9. ↑ ["Gesetzentwurf der Bundesregierung: Entwurf eines Gesetzes zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe"](http://dip21.bundestag.de/dip21/btd/18/085/1808579.pdf)(PDF)(in German). Deutscher Bundestag. May 30, 2016. p. 20. Drucksache 18/8579.
10. ↑ ["Svensk författningssamling Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor"](http://www.notisum.se/rnp/sls/sfs/20050026.pdf)(PDF)(in Swedish) (published February 15, 2005). February 3, 2005. SFS 2005:26.
11. ↑ ["Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html)(in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
12. ↑ ["Schedule 2: Part I: Class A Drugs"](http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I).*"Misuse of Drugs Act 1971"*. UK Government. Retrieved August 20, 2020.
13. ↑ ["Chapter 893: Drug Abuse Prevention and Control"](http://leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html).*The 2019 Florida Statutes*. The Florida Legislature. Retrieved August 21, 2020.NewPP limit report Cached time: 20251218075055 Cache expiry: 1209600 Dynamic content: false Complications: [] [SMW] In‐text annotation parser time: 0.053 seconds CPU time usage: 0.343 seconds Real time usage: 0.725 seconds Preprocessor visited node count: 1660/1000000 Post‐expand include size: 96433/2097152 bytes Template argument size: 10208/2097152 bytes Highest expansion depth: 22/40 Expensive parser function count: 0/100 Unstrip recursion depth: 0/20 Unstrip post‐expand size: 15633/5000000 bytes Lua time usage: 0.280/7 seconds Lua virtual size: 8.62 MB/50 MB Lua estimated memory usage: 0 bytes ExtLoops count: 11Transclusion expansion time report (%,ms,calls,template) 100.00% 587.900 1 -total 25.76% 151.434 9 Template:Cite_web 20.97% 123.283 1 Template:Effects/base 20.51% 120.606 1 Template:Effect_list 20.00% 117.587 2 Template:Effect_column 18.58% 109.215 5 Template:Citation_needed 16.58% 97.446 1 Template:Effects/physical 16.10% 94.656 2 Template:Fix 16.07% 94.448 5 Template:Effect_panel 15.53% 91.330 2 Template:Cite_book